Haleon (LON:HLN) Hits New 52-Week High at $386.05

Haleon plc (LON:HLN)’s stock price reached a new 52-week high on Wednesday . The stock traded as high as GBX 386.05 ($5.08) and last traded at GBX 385.10 ($5.06), with a volume of 12705133 shares trading hands. The stock had previously closed at GBX 382.40 ($5.03).

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank increased their target price on Haleon from GBX 410 ($5.39) to GBX 447 ($5.88) and gave the stock a “buy” rating in a research note on Monday, August 5th.

Haleon Stock Performance

The stock has a market capitalization of £35.50 billion, a P/E ratio of 3,237.50, a PEG ratio of 1.60 and a beta of 0.16. The stock’s 50-day simple moving average is GBX 355.56 and its 200 day simple moving average is GBX 336.77. The company has a debt-to-equity ratio of 54.18, a current ratio of 0.84 and a quick ratio of 0.93.

Haleon Cuts Dividend

The business also recently declared a dividend, which will be paid on Thursday, September 19th. Investors of record on Thursday, August 15th will be paid a GBX 2 ($0.03) dividend. The ex-dividend date of this dividend is Thursday, August 15th. This represents a yield of 0.57%. Haleon’s dividend payout ratio (DPR) is currently 5,000.00%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.